Invention Grant
US08344133B2 Neoglycorandomization and digitoxin analogs 有权
神经保护和洋地黄毒苷类似物

Neoglycorandomization and digitoxin analogs
Abstract:
The present invention provides methods of producing compounds with enhanced desirable properties and diminished side effects as well as the compounds produced by the methods. In preferred embodiments, methods of the present invention use a universal chemical glycosylation method that employs reducing sugars and requires no protection or activation. In a preferred embodiment, the invention provides neoglycoside digitoxin analogs that include compounds with significantly enhanced cytotoxic potency toward human cancer cells and tumor-specificity, but are less potent Na+/K+-ATPase inhibitors in a human cell line than digitoxin.
Public/Granted literature
Information query
Patent Agency Ranking
0/0